NCT03755700 Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization Status UNKNOWN Phase PHASE3
NCT03753022 Effects of PEEP on Parameters of Tissue Perfusion in Patients Post Cardiac Surgery Status UNKNOWN Phase NA
NCT03752515 A Registry Study on Genetics and Biomarkers of Acute Coronary Syndrome Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03745053 XLIMus Drug Eluting Stent: a randomIzed Controlled Trial to Assess Endothelization Status COMPLETED Phase NA
NCT03743090 Influence of Extracorporeal Circulation on the Development of OSA (Obstructive Sleep Apnea) Status WITHDRAWN Phase N/A
NCT03739073 Can we Predict COronary Resistance By EYE Examination ? (COREYE) Status COMPLETED Phase NA
NCT03738631 Cardiac Biomarkers After Marathon Running and Coronary Atherosclerosis Status COMPLETED Phase N/A
NCT03737565 Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) Status COMPLETED Phase N/A
NCT03731936 Artificial Intelligence to Assess the Association Between Facial Characteristics and Coronary Artery Diseases Status COMPLETED Phase N/A
NCT03729739 Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT03729401 Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND Status TERMINATED Phase PHASE4
NCT03728127 Brazilian Cardioprotective Diet and Nuts in Post-acute Myocardial Infarction Status COMPLETED Phase NA
NCT03726892 Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT) Status UNKNOWN Phase NA
NCT03721614 Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. Status UNKNOWN Phase NA
NCT03718559 Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT03718429 Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies Status COMPLETED Phase PHASE4